Ziosoft – Generations Beyond Advanced Visualization

Transforming how you think of

Since 1998, Ziosoft has provided cutting-edge advanced visualization and analysis solutions to health professionals across the world. As a recognized leader in the field, Ziosoft is committed to bringing innovations to the dynamic world of medical imaging and addressing the ever-evolving and complex needs of scientific research and healthcare.

Scalability

Consolidate and lower costs by integrating Ziosotation2’s highly scalable infrastructure into your existing systems.

Extensive Clinical Solutions

Ziostation2 offers an extensive suite of multi-modality and multi-speciality protocols designed to tackle the most demanding clinical challenges.

CUSTOMIZABLE WORKFLOWS

We understand every facility has different needs. Let us empower our workflow with Ziostation2’s fully customizable protocols and user interfaces.

Superior Performance

Ziostation2 delivers superb performance with the extreme speed and reliability to handle your largest studies and transmit the highest resolution images.

Request a demo and see the true power of Ziostation2 for yourself

Get Started

What Our Customers Think

“The imaging community has been waiting for this level of quality. I’ve never seen imaging this ‘lifelike’ outside of surgery.”

Ronald P. Karlsberg, MD, FACP, FACCDavid Geffen School of Medicine

“It was critical to have a budget friendly solution, yet one that added great value in line with our high-end strategy for excellent patient care and befitting the reputation of the hospital. The Ziostation delivers superior image quality for a wide range of clinical applications across multiple imaging modalities.”

Thomas Frauenfelder, MD University Hospital Zurich

“The images produced by applying PhyZiodynamics technology to multiple modality scans are both breathtaking and accurate. The ability to produce 3D images with such high fidelity motion coherence will enable us to obtain reliable 4D motion analysis data for planning advanced surgical and therapeutic patient outcomes.”